One of the most important scientific HIV/AIDS conferences will open next week in San Francisco—the 17th Conference on Retroviruses and Opportunistic Infections. You can get news from this invitation-only event here at Science Speaks, as well as at www.aidsmap.com, which will be providing in-depth coverage of the conference. Science Speaks will have updates on the new HIV/AIDS science presented at CROI, as well as associated policy implications of new approaches to HIV treatment, prevention and care.
The goals of controlling HIV sound like a straight forward series of three consecutive steps, one following another, when discussed in global and domestic epidemic-ending plans. […]
The announcement Wednesday of U.S. Food and Drug Administration approval of pretomanid, a new tuberculosis drug that has been part of a ground-breaking treatment regimen against […]
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
With a report showing that 2018 yielded the highest case numbers seen so far of a paralyzing condition largely among children who had been sick with […]